Home Blog Page 532

NEXEN TYRE Expands in Australia with Launch of High-Performance N’BLUE S

– Targeting RE markets in Latin America and Asia-Pacific with product proven in Europe and OE sales

SEOUL, South Korea, March 15, 2026 /PRNewswire/ — NEXEN TYRE, a leading global tyre manufacturer, announced the launch of its high-performance summer tyre the N’BLUE S in Australia, as it accelerates its expansion in the global replacement (RE) market. Following its success in the European market, the company is now introducing this proven product to Australia to diversify its premium portfolio and support long-term growth in the Asia-Pacific region.

Nexen Tyre’s high-performance summer tyre, N’Blue S
Nexen Tyre’s high-performance summer tyre, N’Blue S

NEXEN TYRE’s launch of the N’BLUE S in Australia is part of the company’s premium global expansion strategy. Optimised for Australia’s diverse driving conditions, the N’BLUE S delivers exceptional stability on wet roads and superior efficiency in everyday driving. This launch marks a significant step forward in the company’s plan to diversify its regional portfolio and meet the structural demand for high-quality summer tyres in the Asia-Pacific region.

The N’BLUE S is a high-performance summer tyre designed with an optimised contact patch structure that reduces rolling resistance for better efficiency and improved handling. It is made from a multifunctional compound with evenly dispersed materials to enhance wet grip, ensuring stable driving on wet roads.

The newly launched N’BLUE S also carries NEXEN TYRE’s proprietary EV ROOT mark. This designation is granted to products engineered to deliver optimal performance across internal combustion engine, hybrid, and electric vehicles. As electrification accelerates globally, the company expects to broaden its sales base by offering a single product suitable for vehicles across diverse powertrains.

The N’BLUE S’s performance has already been proven in both the European replacement market and original equipment (OE) sales. It has been supplied as OE for European models as well as electric vehicles such as the Hyundai Casper EV, Kia Niro and PV5. NEXEN TYRE aims to build on the product’s proven competitiveness with global automakers by expanding consumer touchpoints through broader penetration into the replacement market.

NEXEN TYRE is strengthening its presence in Australia by enhancing both its logistics infrastructure and its retail competitiveness. With the opening of a new warehouse in Rocklea, Queensland in 2025, the company now operates three dedicated logistics hubs across New South Wales, Victoria, and Queensland. This has enabled significantly shorter lead times and superior inventory responsiveness for NEXEN TYRE’s partners nationwide. As part of its continued investment in the Australian market, the company is also planning to establish a new warehouse in Western Australia later this year further enhancing its nationwide distribution efficiency.

Starting in 2026, NEXEN TYRE AUSTRALIA plans to roll out its global retail branding program, the Nexen Point Dealer Program, nationwide. This will unify external signage, in-store interiors and merchandising guidelines to ensure a consistent brand experience. By integrating its three logistics hubs with a unified distribution and branding strategy, NEXEN TYRE aims to accelerate its growth in the local RE tyre market.

“The launch of the N’BLUE S in Australia reflects our commitment to delivering high-performance summer tyres across the Asia-Pacific region,” said John Bosco (Hyeon Suk) Kim, CEO of NEXEN TYRE. “With our strengthened local logistics and retail network, we will continue to expand our presence and enhance our competitive edge in the Australian replacement market.”

###

About NEXEN TYRE

Established in 1942, NEXEN TYRE is a global tyre manufacturer headquartered in South Korea. As one of the world’s fastest growing tyre manufacturers, the company does business in approximately 150 countries around the world and owns four manufacturing plants, two in Korea (Yangsan and Changnyeong), one in Qingdao, China, and a fourth in Žatec, Czech Republic, that began operation in 2019. NEXEN TYRE produces tyres for passenger cars, SUVs, and light trucks based on advanced technology and design excellence. As proof of their quality and technological excellence, the company’s OE tyres are used by global premium car makers in various countries around the world. In 2014, NEXEN TYRE achieved a grand slam by winning the world’s top four design awards, the first tyre maker in the world to do so.

For more information, please visit https://newsroom.nexentire.com/

 

CollectForU Expert and Debt Hunter Jointly Report Critical Credit Risk Management Gaps Among Hong Kong SMEs


HONG KONG SAR – Media OutReach Newswire – 16 March 2026 – Professional credit management firms CollectForU Expert and Debt Hunter today jointly released a comprehensive industry observation report regarding the financial health of local enterprises. The report indicates that small and medium enterprises (SMEs) in Hong Kong are currently facing significant liquidity risks as payment cycles across supply chains continue to lengthen. This trend has resulted in a critical imbalance between recorded profits and actual cash flow.

CollectForU Expert and Debt Hunter Jointly Report Critical Credit Risk Management Gaps Among Hong Kong SMEs
CollectForU Expert and Debt Hunter Jointly Report Critical Credit Risk Management Gaps Among Hong Kong SMEs

Widespread Absence of Credit Defense Mechanisms
According to the findings, more than 70% of Hong Kong SMEs lack robust credit defense mechanisms. The report highlights that many businesses fail to perform in-depth credit due diligence on new clients or establish firm payment thresholds.

Alex Yeung, founder of CollectForU Expert, noted that a high percentage of SMEs remain in a state of low defense regarding credit management. Yeung emphasized that bad debts in B2B transactions often have a domino effect. He stated that if a company focuses solely on gross margins while ignoring the operational stability of a counterparty, a single large-scale default could potentially eliminate an entire year of net profit. He recommends that businesses establish standardized defense systems including background checks, credit limit settings, and continuous monitoring to ensure operational safety.

The 90-Day Recovery Threshold
The joint report identifies the 90-day mark as a critical watershed for the successful recovery of overdue accounts. Many SME owners hesitate to take action during the early stages of delinquency to preserve client relationships, which inadvertently increases the risk of asset dissipation or insolvency proceedings by the debtor.

Obis Tsang, founder of Debt Hunter and a professional mediator, stated that the success rate of commercial debt recovery is inversely proportional to the duration of the delinquency. Once a debt is overdue by more than 90 days, the probability of recovery decreases significantly. Tsang suggested that early intervention by specialized third parties should be viewed as a rational tool for commercial negotiation. Engaging mediation-focused professionals can facilitate viable repayment plans and prevent the loss of claims due to excessive delays.

Strategic Recommendations for SMEs
In response to the current economic environment, both institutions advise SMEs to adopt a proactive approach to credit defense rather than waiting for defaults to occur:

  • Strengthen Pre-Contract Screening: Implement standardized credit assessments before finalizing commercial agreements.
  • Establish Warning Mechanisms: Define clear payment deadlines and take immediate action when clients breach these thresholds.
  • Seek Timely Professional Assistance: Introduce expert third-party advice early in the delinquency period to stabilize cash flow.

CollectForU Expert and Debt Hunter intend to continue their collaboration to standardize credit management practices and enhance the financial resilience of Hong Kong SMEs.
Hashtag: #CreditManagement #AccountsReceivable #CollectForU #DebtHunter #DebtCollection #HongKongSMEs




Wechat: DebtHunterHK

The issuer is solely responsible for the content of this announcement.

About Debt Hunter

Debt Hunter is a commercial debt resolution agency founded by professional mediator Obis Tsang. The firm prioritizes negotiation and mediation as its core service philosophy. Debt Hunter was awarded the “Mediate First” Pledge Star Logo Award by the Hong Kong Department of Justice, in recognition of its commitment to mediation practices. Recognized by HackerNoon as a “Startups of the Year 2023” in Hong Kong, the firm employs a strategy involving legal compliance, behavioral insights, and big data to resolve commercial disputes. The agency has processed over 10,000 commercial cases to provide rational asset protection for its clients.

Website:

About CollectForU Expert

CollectForU Expert was founded by Alex Yeung, who possesses over 15 years of practical experience in commercial debt recovery and credit management. The firm provides integrated solutions ranging from credit risk early-warning systems to accounts receivable recovery, with a focus on maintaining corporate reputation and long-term partnerships. CollectForU Expert utilizes behavioral psychological analysis and commercial negotiation techniques to resolve complex financial disputes and helps SMEs optimize internal credit processes.

Website:

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara®[1], Floretyrosine F 18 or 18F-FET), an investigational PET[2] imaging agent for the characterization of recurrent or progressive glioma (brain cancer) from treatment related changes in both adult and pediatric patients.

Telix has resubmitted the NDA with the additional data requested by the FDA. The Company believes, based on the Type A meeting and ongoing consultation with the FDA, that the additional data and statistical analysis, along with the primary data set provided in the original submission, appropriately addresses the Complete Response Letter[3].

Given the potential to address significant unmet medical need, TLX101-Px has been granted Orphan Drug[4] and Fast Track[5] designations by the FDA. PET imaging with 18F-FET is already included in international clinical practice guidelines for the imaging of gliomas[6], however there is currently no FDA-approved targeted amino acid PET agent for adult and pediatric brain cancer imaging commercially available in the U.S.

Dr. David N. Cade, Telix Group Chief Medical Officer, said, “We appreciate the FDA’s recognition of the critical unmet need to improve the diagnosis and management of glioma, particularly in the post-treatment setting. Our resubmission is supported by an extensive and compelling data set – particularly so for an orphan indication. We are grateful to our global clinical collaborators, who share our commitment to ensuring patients in the U.S. can benefit from this important patient management tool.”

Maggie Haynes, Executive Director, Head for the Cure Foundation, added: “Our community is encouraged by the FDA’s ongoing engagement and guidance to the sponsor and support for the Expanded Access Program for TLX101-Px. We are hopeful of an expedited review, so this important and proven imaging option can become available to those who urgently need it.”

About TLX101-Px

TLX101-Px is a PET imaging agent, which has been granted fast track and orphan drug designations by the FDA as an imaging agent for the characterization of recurrent or progressive glioma from treatment related changes. TLX101-Px targets membrane transport proteins known as LAT1 and LAT2[7]. This enables TLX101-Px to be potentially utilized as a companion diagnostic agent to TLX101-Tx (iodofalan 131I), Telix’s LAT1-targeting glioblastoma (GBM) therapy candidate, currently under investigation in the pivotal IPAX-BrIGHT study[8]

About gliomas in the U.S.

Gliomas are very diffusely infiltrative tumors that affect the surrounding brain tissue. They are the most common form of central nervous system (CNS) neoplasm that originates from glial cells, accounting for approximately 30% of all brain and CNS tumors and 80% of all malignant brain tumors[9]. In the U.S., there are six cases of gliomas diagnosed per 100,000 people every year[10]. GBM is a high-grade glioma and the most common and aggressive form of primary brain cancer, with approximately 22,000 new cases diagnosed annually in the U.S.[11]. The mainstay of treatment for GBM comprises surgical resection, followed by combined radiotherapy and chemotherapy. Despite such treatment, recurrence occurs in almost all patients[12], with an expected survival duration of 12-15 months from diagnosis[13]

About Telix Pharmaceuticals Limited

Telix is a global biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies, with the goal to address significant unmet medical needs in oncology and rare diseases. With international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan, Telix is headquartered in Melbourne, Australia. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Illuccix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally. Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection) has been approved by the U.S. FDA[14]. TLX101-Px and TLX101-Tx have not received marketing authorizations in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

Telix Investor Relations (Global)

Ms. Kyahn Williamson

SVP Investor Relations and Corporate
Communications

kyahn.williamson@telixpharma.com

Telix Investor Relations (U.S.)  

Ms. Annie Kasparian  

Director Investor Relations and Corporate
Communications  

annie.kasparian@telixpharma.com 

Telix Investor Relations (Australia)

Ms. Charlene Jaw

Associate Director Investor
Relations

charlene.jaw@telixpharma.com

Media Contact
Eliza Schleifstein
917.763.8106 (Mobile)
Eliza@schleifsteinpr.com

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

[1] Brand name subject to final regulatory approval.
[2] Positron emission tomography.
[3] Telix ASX disclosure April 28, 2025.
[4] Telix ASX disclosure October 6, 2020.
[5] Telix ASX disclosure April 16, 2024. Fast Track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important new drugs to the patient earlier. More: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track
[6] Galldiks et al. Lancet Oncol. 2025 (Joint guidelines from the European Association of Nuclear Medicine (EANM), European Association of Neuro-Oncology (EANO), Society of Nuclear Medicine and Molecular Imaging (SNMMI), Response Assessment in Neuro-Oncology (RANO), The European Society for Pediatric Oncology and The Response Assessment in Pediatric Neuro-Oncology for the characterization of recurrence in glioma patients); National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers V1.2025.
[7] L-type amino acid transporters 1 and 2.
[8] ClinicalTrials.gov ID: NCT07100730.
[9] Goodenberger et al. Cancer Genet. 2012.
[10] Mesfin et al. StatPearls. 2024.
[11] Ostrom 2022, CBTRUS (Central Brain Tumor Registry of the United States) Statistical Report.
[12] Park et al. Journal of Clinical Oncology. 2010.
[13] Ostrom et al. Neuro Oncol. 2018.
[14] Telix ASX disclosure March 21, 2025.

KuCoin Launches Skills Hub, Turning Agent-Ready Skills Into Crypto Capabilities

PROVIDENCIALES, Turks and Caicos Islands, March 15, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, today announced the launch of KuCoin Skills Hub, an evolving open skills marketplace designed to give AI agents broader crypto-native access through standardized, modular capabilities. KuCoin Skills Hub is compatible with mainstream agent frameworks and development environments, helping retail users access crypto through more intuitive natural-language interactions while enabling institutions, developers, and quantitative teams to build automated research, trading, and asset management workflows more efficiently. Rooted in KuCoin’s belief that technology should serve people and be built on trusted, transparent infrastructure, the launch marks a further step in modularizing crypto capabilities for practical AI adoption in real-world use cases.


As AI agents evolve from conversational tools into execution-oriented systems, crypto infrastructure must become more accessible, composable, and action-ready. Historically, fragmented tools, complex interfaces, and technical barriers have limited advanced crypto workflows to a relatively narrow group of users. KuCoin Skills Hub is designed to help close that gap by converting complex underlying functions into structured skills that can be accessed more naturally and deployed more broadly.

Trust, security, and execution control remain central to the platform’s architecture. KuCoin Skills Hub incorporates safeguards around permission control, credential isolation, sensitive data protection, execution boundaries, and exception handling to support more secure and controllable deployment in real-world environments.

Through natural-language interaction, users can access market insights, monitor signals and market activity, and query exchange data more efficiently through the Skills Hub. Support for deeper interaction scenarios such as wallet operations, on-chain insights, liquidity provision, staking, lending, and yield strategies will be introduced in future releases, enabling a more unified workflow for insight, decision-making, execution, and broader ecosystem participation.

“AI is changing how people interact with the crypto economy, but the real value of technology lies in whether it can serve real users on top of infrastructure they can trust,” said BC Wong, CEO of KuCoin. “Built on KuCoin’s expanding ecosystem and broader crypto-native AI initiatives, KuCoin Skills Hub is designed to transform complex crypto capabilities into more intuitive, scalable, and usable modules — making crypto more accessible for everyday users while giving institutions and developers a more flexible foundation for the next generation of intelligent applications. We see this as an important step toward a more open, practical, and trustworthy AI-enabled crypto ecosystem.”

Looking ahead, KuCoin Skills Hub will continue to expand its skills library, data sources, protocol integrations, and operational capabilities, further strengthening the open infrastructure layer needed for the next phase of AI-enabled crypto innovation.

About KuCoin

Founded in 2017, KuCoin is a leading global crypto platform trusted by over 40 million users across 200+ countries and regions. The platform delivers innovative digital-asset services, offering access to 1,000+ listed tokens, spot and futures trading, institutional wealth management, and a Web3 wallet.

Recognized by Forbes and Hurun, KuCoin holds SOC 2 Type II and ISO 27001:2022 certifications, underscoring its commitment to top-tier security. With AUSTRAC registration in Australia and a MiCA license in Austria, KuCoin continues expanding its regulated footprint under CEO BC Wong, building a reliable and trusted digital-asset ecosystem.

Learn more: www.kucoin.com

2026 Changan Global Testing Season Hits Mexico with Four New Models

  • Four new Changan models debuted in Mexico: CHANGAN Alsvin PLUS, CS35 MAX, new CS55 PLUS, and CS75 PLUS.
  • With responsive powertrains, intelligent safety and spacious interiors, the four models delivered proven performance and comfort.

MEXICO CITY, MEXICO – Media OutReach Newswire – 15 March 2026 – Changan has launched four all-new upgraded models in Mexico—the CHANGAN ALSVIN PLUS sedan and three SUVs: the CS35 MAX, CS55 PLUS, and CS75 PLUS—responding to growing market demand for vehicles that integrate technology and efficiency.

Following the launch, more than 150 dealers, investors, and media had a 287-km test drive across Yucatán Peninsula as part of the 2026 Changan Global Testing Season. The route, from Cancún to Playa del Carmen via Chiquilá and Holbox, spanned highways, coastal roads, and rural paths, where stability, intelligence, safety, and long-distance comfort were proven.

Performance Meets Comfort: New Models for Every Journey

Powered by the BlueCore 3.0 engine and 7-speed DCT, the new CHANGAN CS55 PLUS delivered responsive performance across the route. Its Ark Cage body structure combined with 12 intelligent safety features, including IACC, LCC, FCW, and AEB, and 540° camera assist, provided reassuring protection on the rugged and windy jungle roads and coastal highways.

The ADAS system was also integrated into the CS75 PLUS to reduce driver fatigue, while the 37-inch triple-screen display provided easy access to navigation and entertainment. The ventilated front seats ensured comfort in temperatures exceeding 30°C, and the zero-gravity passenger seat enhanced relaxation with a massage function during extended drives.

All four models feature multi-screen smart cockpits with wireless CarPlay/Android Auto, voice control, OTA updates, and remote app control. Spacious interiors and the BlueCore 3.0 powertrain system also extend to the Alsvin PLUS and CS35 MAX, delivering a blend of performance and comfort.

Growth in Action: Changan’s Local Commitment to Mexico

In 2025, Changan achieved over 56% sales growth in Latin America, with Mexico growing 184%. In terms of local operations, a new 8,000+ m² parts warehouse, operational in early 2026, will further enhance service capacity and parts supply. Mexico has become increasingly central to Changan’s global footprint.

This commitment was on full display in Yucatán. The route captured the country’s iconic landscapes while reflecting real-world driving conditions: unpredictable weather and varied terrain. Changan’s expanded portfolio reaffirms its dedication to delivering products that combine global innovation with local needs.
Hashtag: #Changan

The issuer is solely responsible for the content of this announcement.

Ping An’s Financial LLM Ranks First in CNFinBench Evaluation

HONG KONG and SHANGHAI, March 15, 2026 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (“Ping An” or “the Group”; HKEX: 2318/82318; SSE: 601318) announced that PingAnGPT-Qwen3-32B, the Group’s financial large language model (LLM), achieved the highest overall score on the CNFinBench leaderboard, an authoritative benchmarking system for large language models in the industry, as of March 15. 

The latest CNFinBench evaluation included a range of models representing the forefront of global artificial intelligence (AI) capabilities, including GPT-4o and Claude Sonnet 4, as well as mainland Chinese open-source models such as DeepSeek-R1 (671B) and Qwen3-235B-A22B.

CNFinBench is an industry leading benchmark for evaluating financial LLM capabilities in Chinese mainland, jointly developed by Shanghai Artificial Intelligence Laboratory and leading authorities in the financial industry. It assesses models across five dimensions: financial expertise, business understanding and analysis, reasoning and computation, compliance and risk control, and application security.

In the latest evaluation, PingAnGPT‑Qwen3‑32B demonstrated outstanding performance across multiple core metrics, including financial factual reasoning and computation, financial knowledge Q&A, and financial compliance and risk control. The model showcased high numerical accuracy and rigorous logical reasoning, especially in application scenarios such as financial investment research and risk measurement. These strengths highlight its significant practical value and advantages in safety and controllability.

PingAnGPT-Qwen3-32B has been deployed across the Group and supports 97 real‑world business scenarios, including auto insurance claims, customer service, expense auditing, and intelligent call operations. The model continues to empower the business, driving greater efficiency and service quality.

Through strengthening its AI capabilities, accelerating model optimization and iteration, and deepening scenario‑based deployment, Ping An continues to translate technological strengths into tangible customer value. The Group remains committed to meeting the evolving customer needs by focusing on worry‑free, time‑saving, and cost‑efficient services through high‑quality, digital financial offerings.

About Ping An Insurance (Group) Company of China, Ltd.

Ping An Insurance (Group) Company of China, Ltd. (HKEX:2318 / 82318; SSE:601318) is one of the largest financial services companies in the world. It strives to become a world-leading provider of integrated finance, health and senior care services. Under the technology-enabled “integrated finance + health and senior care” dual-pronged strategy, the Group provides professional “financial advisory, family doctor, and senior care concierge” services to its nearly 250 million retail customers. Ping An advances intelligent digital transformation and employs technologies to improve financial businesses’ quality and efficiency and enhance risk management. The Group is listed on the stock exchanges in Hong Kong and Shanghai. As of the end of December 2024, Ping An had more than RMB12 trillion in total assets. The Group ranked 27th in the Forbes Global 2000 list in 2025, 47th in the Fortune Global 500 list in 2025, and ranked AAA in MSCI ESG Ratings in 2025.

For more information, please visit the www.group.pingan.com and follow our LinkedIn page – PING AN.

Spring Into Healthy Breathing: Varon Offers Tips for Travel and Wellness with Oxygen Support

NEW YORK, March 15, 2026 /PRNewswire/ — Spring is here, bringing warmer weather, outdoor adventures, and family travel. For individuals who rely on supplemental oxygen, enjoying the season safely requires preparation and the right equipment. VARON is sharing expert guidance for breathing health and travel while highlighting its lineup of home oxygen concentrators and portable oxygen concentrator for travel.

“Springtime activities can be energizing, but for those with chronic respiratory conditions, maintaining optimal oxygen levels is crucial,” said VARON CEO. “With the right strategies and reliable oxygen support, anyone can embrace the season safely and comfortably.”

Breathing Health Tips for Spring

  1. Minimize Allergen Exposure – Spring pollen can trigger respiratory symptoms. Using a home or portable oxygen concentrator ensures consistent oxygen support even during allergy flare-ups.
     
  2. Stay Hydrated – Proper hydration keeps airways moist and supports oxygen absorption.
     
  3. Exercise Smartly – Light outdoor activity enhances lung capacity and circulation; monitor oxygen levels when trying new routines.
     
  4. Travel Preparedness – Fully charge your portable oxygen concentrator, review airline oxygen policies, and carry extra batteries for extended excursions.
     
  5. Routine Device Maintenance – Clean filters and regularly inspect your devices to maintain reliable oxygen delivery.

Travel Tips with Portable Oxygen Concentrators

Traveling with oxygen doesn’t have to be challenging. Varon portable oxygen concentrators are lightweight, reliable, and supports extra replaceable battery for additional oxygen support, making them ideal for spring trips:

  • Compact and portable design for easy carrying
     
  • Adjustable oxygen flow to accommodate activity levels
     
  • Long-lasting, replaceable batteries for uninterrupted oxygen supply
     
  • Dual delivery modes for consistent and reliable oxygen

Models such as the VP-8 Lite, VP-6 Continuous Flow, and VP-8G Ultra Portable combine convenience with clinical-grade oxygen delivery, enabling users to enjoy day trips, long drives, or air travel safely.

Spring Day Sale: Enhance Your Health and Travel Readiness

VARON is celebrating spring with its Spring Day Sale, offering 18% off sitewide and up to 40% off featured models. This is the perfect time to explore portable or home oxygen solutions designed to support independence, mobility, and overall health.

VARON’ s featured oxygen concentrator machine combine high-purity oxygen delivery, user-friendly design, and advanced functionality to maintain healthy oxygen levels at home or on the go:

  • VP-8 Lite – Lightweight portable oxygen concentrator with adjustable pulse flow (1–7 settings) and dual delivery modes for travel or daily use.
     
  • VP-6 Continuous Flow – Continuous flow oxygen (1–6L) with a built-in nebulizer function, long-lasting replaceable battery, and convenient remote control.
     
  • VP-8G Ultra Portable – Ultra-light, compact design with flexible pulse flow (1–8 settings) for active users seeking maximum portability.
     
  • VH-2 Pro Home – Home oxygen concentrator with adjustable continuous flow, built-in nebulization, and an intuitive LED control panel.
     
  • Serene 3 (3L) and Serene 5 (5L) – Medical-grade home oxygen concentrators with quiet operation, adjustable flow rates, and large humidification bottles to maintain comfort and respiratory health.

These devices ensure reliable oxygen delivery whether at home, on the go, or traveling, helping users maintain healthy oxygen levels and enjoy spring activities safely.

Additional Tips for Healthy Spring Travel with Oxygen

  1. Plan Your Routes – Identify rest stops, medical facilities, and oxygen refill stations along your travel route.
     
  2. Pack Smart – Include extra batteries, chargers, and essential accessories in a dedicated travel bag.
     
  3. Temperature Awareness – Keep oxygen devices out of direct sunlight and avoid extreme heat or cold to maintain performance.
     
  4. Monitor Oxygen Levels – Use a portable pulse oximeter to ensure safe oxygen saturation while traveling.
     
  5. Stay Active Safely – Incorporate short walks or gentle exercise, pacing yourself according to oxygen needs.
     
  6. Emergency Preparedness – Carry prescriptions, device manuals, and your doctor’s contact information for unexpected situations.
     
  7. Travel Companions – Inform travel partners of your oxygen needs to provide assistance if necessary.

“Proper preparation allows individuals to enjoy spring adventures without compromising breathing health,” VARON CEO said. “With VARON oxygen concentrator machine, users can maintain independence, mobility, and confidence wherever the season takes them.”

About Varon

VARON provides a range of portable and home oxygen concentrators designed to support respiratory wellness and quality of life. Varon products empower users to remain active, healthy, and independent.

Media Contact
Company Name: VARON
Email: official@varoninc.com
Country: United States
Website: https://monportlaser.com/

Monport UV Laser Now Available for High-Precision, Multi-Material Micro Marking

NEW YORK, March 15, 2026 /PRNewswire/ — Monport Laser has made its GM UV Laser Engraver available for businesses seeking high-precision micro marking across a wide range of materials. The new UV laser marking system, offered in 6W and 10W configurations, is designed to support detailed engraving applications while maintaining surface integrity on delicate or heat-sensitive materials.

High-Precision Laser Engraving with UV Technology

UV laser engraving is a marking process that uses a short-wavelength ultraviolet laser to engrave surfaces through photochemical reactions rather than thermal burning. This method enables high-precision laser engraving while significantly reducing the heat-affected zone on the material.

Because the process relies on photochemical interaction rather than high heat, UV laser technology is commonly described as heat-free marking or “cold marking.” This allows the UV laser engraver to produce clear, permanent engravings without the discoloration, warping, or burning that can occur with other laser systems.

Compared with traditional laser technologies such as CO2 laser engraving and fiber laser engraving, a UV laser marking system offers greater precision when working with delicate surfaces. Materials such as plastics, coated metals, and transparent substrates often respond better to ultraviolet wavelengths, making UV laser ideal for applications that require both accuracy and surface protection.

For industries that demand high-precision laser engraving and heat-free marking, ultraviolet laser technology has become an increasingly valuable solution.

Application Scenarios for UV Laser Engravers

The versatility of a UV laser marking system makes it suitable for a wide variety of professional applications. Manufacturers and designers increasingly rely on UV laser engravers for tasks that require precise markings on sensitive materials.

Common application scenarios include:

Electronics manufacturing
Circuit boards, connectors, chips, and micro components often require micro-level identification markings. A UV laser engraver can create highly detailed codes and numbers without damaging the component surface.

Medical device marking
Medical instruments and equipment require permanent and highly legible identification marks. The precision of a UV laser marking system supports these strict labeling requirements.

Product branding and customization
Brands can use a UV laser engraver to add logos, decorative designs, or product information to packaging and consumer goods while maintaining a premium finish.

Jewelry and luxury goods
Delicate surfaces and intricate details benefit from the high-precision laser engraving capabilities of ultraviolet technology.

Industrial product identification
Manufacturers can engrave serial numbers, QR codes, and traceability markings with a UV laser marking system while maintaining production efficiency.

These real-world use cases demonstrate how a UV laser engraver supports both creative and industrial engraving needs.

Material Compatibility of a UV Laser Marking System

One of the most important advantages of a UV laser engraver is its multi-material compatibility. According to Monport, the UV laser marking system can engrave more than 1,500 materials, making it a flexible solution for workshops and manufacturing environments.

Compatible materials include:

  • Metals and coated metals
     
  • Plastics and polymers
     
  • Glass and crystal
     
  • Acrylic and transparent materials
     
  • Ceramics
     
  • Electronic components
     
  • Painted or coated surfaces

Because ultraviolet lasers operate with a minimal heat-affected zone, the UV laser marking system can process materials that may be difficult to engrave with other laser types.

For businesses that regularly work with different substrates, this level of compatibility allows a single UV laser engraver to handle a wide variety of production tasks.

Product Highlights of the Monport UV Laser Series

The Monport UV laser engraver combines precision, speed, and user-friendly operation in a single engraving system.

Ultra-fine engraving resolution
The UV laser marking system features a spot size of approximately 0.0019 mm, allowing extremely detailed micro markings. This level of precision supports applications requiring fine text, intricate designs, or small identification codes.

Minimal heat-affected zone
Because the UV laser engraver uses heat-free photochemical marking, materials remain free from burn marks, discoloration, or deformation.

High-speed engraving performance
Equipped with an industrial galvanometer scanning system, the UV laser marking system supports engraving speeds of up to 10,000 mm per second, enabling efficient production workflows.

Multiple power options
The Monport UV series is available in 6W and 10W configurations, allowing users to choose a UV laser engraver that best fits their production needs.

Integrated cooling system
The system includes a water chiller integration that helps maintain stable operating temperatures and ensures consistent performance during extended engraving sessions.

User-friendly software and workflow
Each UV laser marking system includes free engraving software and is compatible with LightBurn, enabling users to easily create and manage engraving projects.

These features make the Monport UV laser engraver suitable for both experienced professionals and businesses exploring UV laser technology for the first time.

Pre-Sale Offer and Limited Availability

To mark the release of the new system, Monport is offering a limited pre-sale promotion for the UV laser series.

Customers who participate in the promotion can receive $600 off the purchase price of the UV laser engraver. The offer is available for a limited time and may be subject to availability while supplies last.

Monport notes that priority shipping will be provided for early orders placed during the promotional period.

More details about the promotion and product specifications are available on the official Monport promotion page.

Expanding Access to High-Precision UV Laser Engraving

With the release of its new UV laser marking system, Monport aims to provide businesses with a reliable tool for high-precision laser engraving, heat-free marking, and multi-material compatibility. The combination of precision, speed, and versatility makes the UV laser engraver a valuable addition for manufacturers, creators, and product designers.

The Monport UV laser series is now available through the company’s official website.

About Monport

Monport Laser develops laser engraving and cutting equipment designed for makers, small businesses, and industrial manufacturers. Its product lineup includes CO₂, fiber, and UV laser systems used in applications ranging from custom product creation to industrial marking.

Media Contact
Monport Laser
Email: official@monportlaser.com
Website: https://monportlaser.com